Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) (“Bionano” or the “Company”) today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the ...

PM ETSAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 ...

Bionano Genomics, Inc. BNGO will release earnings results for its fourth quarter, after the closing bell on Monday, March 23.

Bionano Genomics, Inc. announced a settlement agreement that modifies its existing senior secured convertible debentures due in May 2024. The amendment defers the December 2024 amortization payment ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Bionano Genomics, Inc. announced a 1-for-60 reverse stock split of its common stock effective January 24, 2025, following approval by stockholders at a special meeting on January 15. Upon market ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

Attributed Q4 revenue declines to supply constraints from a manufacturing partner for silicon wafers, creating a backlog of ...

Bionano Genomics, Inc. beats earnings expectations. Reported EPS is $-1.59292, expectations were $-1.81. Operator: Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call.

Operator: Good day, and welcome to the Bionano Second Quarter 2025 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Kelly Gura ...